Home › Funds › Brooklyn Investment Group › NVS

Brooklyn Investment Group position in NVS

NOVARTIS AG · Health Care

Brooklyn Investment Group reported holding 96,271 shares of NVS (NOVARTIS AG) in its Q1 2026 13F filing — a position valued at US$14.7M, representing 0.46% of its reported portfolio and ranking #28 among its reported holdings. Brooklyn Investment Group has disclosed NVS holdings in 6 of the last 6 reported quarters, going back to Q4 2024.

Latest position (Q1 2026)96.27K sh
Reported value held$14.71M
Portfolio Weight0.46%
First reportedQ4 2024
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Brooklyn Investment Group's NVS position evolved

Brooklyn Investment Group first disclosed a stake in NVS in Q4 2024 at 563 shares (US$55K). The position peaked in Q1 2026 at 96,271 shares, worth US$14.7M. Across 6 filings, Brooklyn Investment Group increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 96,271 shares valued at US$14.7M — an increase of 31,323 shares quarter over quarter.. Notable position changes include a 1148% increase in Q1 2025 (shares rose 9% over the following quarter), a 214% increase in Q2 2025 (shares rose 5% over the following quarter), a 202% increase in Q4 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 563 $54.79K New
Q1 2025 7.03K $783.26K Add
Q2 2025 22.09K $2.67M Add
Q3 2025 21.53K $2.58M Reduce
Q4 2025 64.95K $9.04M Add
Q1 2026 96.27K $14.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVS and 13F data

NVS (NOVARTIS AG) is a Health Care company. 24 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.43B), PRIMECAP MANAGEMENT CO/CA/ (US$1.03B), LOOMIS SAYLES & CO L P (US$821.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVS

All NVS fund holders →

FAQ

How long has Brooklyn Investment Group held NVS?

Brooklyn Investment Group has disclosed NVS holdings in 6 of the last 6 reported quarters, going back to Q4 2024.

What is Brooklyn Investment Group's current position in NVS?

As of Q1 2026, Brooklyn Investment Group holds 96.27K shares of NVS (NOVARTIS AG), valued at $14.71M, representing 0.46% of its reported portfolio and ranking #28.

Has Brooklyn Investment Group been buying or selling NVS?

In the latest 13F filing (Q1 2026), Brooklyn Investment Group increased its position in NVS. The position peaked in Q1 2026 at 96.27K shares.

Which other funds hold NVS?

Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.